From LBR-101 to Fremanezumab for Migraine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Works matching IS 11727047 AND DT 2018 AND VI 32 AND IP 11
Results: 7
1
2
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
- Published in:
- 2018
- By:
- Publication type:
- journal article
3
The Cholinergic System as a Treatment Target for Opioid Use Disorder.
- Published in:
- 2018
- By:
- Publication type:
- journal article
4
Ketamine for Refractory Status Epilepticus: A Systematic Review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
5
Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
6
Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
7
Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis.
- Published in:
- CNS Drugs, 2018, v. 32, n. 11, p. 1069, doi. 10.1007/s40263-018-0547-z
- By:
- Publication type:
- Article